Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bausch + Lomb Corporation - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BLCO
New York
2830
www.bausch.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bausch + Lomb Corporation
Insider Stock Buying Reaches US$1.54m On Bausch + Lomb
- Jun 30th, 2025 11:03 am
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
- Jun 30th, 2025 4:58 am
Bausch + Lomb Closes Senior Secured Notes Offering, Refinancing And Upsizes US$2.32 Billion Term Loan Facility
- Jun 26th, 2025 2:55 pm
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
- Jun 26th, 2025 2:30 pm
The Top 5 Analyst Questions From Bausch + Lomb’s Q1 Earnings Call
- Jun 25th, 2025 5:42 am
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
- Jun 23rd, 2025 9:58 am
Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering
- Jun 18th, 2025 2:55 pm
Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering
- Jun 18th, 2025 2:30 pm
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
- Jun 10th, 2025 6:48 am
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States
- Jun 4th, 2025 4:59 am
1 Safe-and-Steady Stock for Long-Term Investors and 2 to Question
- Jun 2nd, 2025 10:36 pm
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
- May 22nd, 2025 5:30 am
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results
- May 21st, 2025 2:30 pm
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
- May 21st, 2025 4:59 am
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States
- May 14th, 2025 4:59 am
BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty
- May 14th, 2025 4:36 am
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
- May 7th, 2025 5:00 am
Bausch & Lomb Corp (BLCO) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Challenges
- May 1st, 2025 1:08 am
Why Bausch + Lomb (BLCO) Shares Are Falling Today
- Apr 30th, 2025 12:23 pm
Bausch + Lomb (NYSE:BLCO) Misses Q1 Sales Targets, Stock Drops 10.4%
- Apr 30th, 2025 5:47 am
Scroll